Shalom Zwiebel: Clinical Practice Evaluating PRP Systems and Supply Partners
Shalom Zwiebel, Clinical Liaison at Renova Wound Care, shared a post on LinkedIn:
“Clinical Practice Evaluating PRP Systems and Supply Partners
As the use of Platelet-Rich Plasma therapy (PRP) continues to expand across wound care, orthopedics, dermatology, and regenerative medicine, the consistency and reliability of PRP preparation systems are essential for achieving predictable clinical outcomes.
Our clinical practice is currently evaluating PRP technologies and supply partners to support ongoing and growing clinical utilization of biologic therapies in patient care.
We are interested in connecting with established manufacturers or authorized distributors that offer:
- Clinically validated PRP preparation systems
- Regulatory-compliant kits and centrifuge platforms
- Consistent platelet concentration and reproducible processing
- Reliable supply chain and clinical support for physician practices
Given the expected clinical volume, we are particularly interested in working with experienced U.S.-based manufacturers or distributors that can support long-term clinical partnerships.
If your organization manufactures or distributes PRP systems, kits, centrifuges, or regenerative medicine technologies, we would welcome the opportunity to learn more about your platform.
Manufacturers or authorized distributors only, please.
Please feel free to reach out via direct message or comment below.”
Stay updated with Hemostasis Today.
-
Sep 23, 2026, 07:28Isabelle Grenier-Pleau: Targeting Von Willebrand Disease to Transform Women’s Health
-
Sep 23, 2026, 07:07Wolfgang Miesbach: Mechanisms of Liver Injury After Hemophilia A Gene Therapy
-
Sep 23, 2026, 06:24Nicolas Gendron: Everolimus and Venous Thromboembolic Risk in Kidney Transplantation
-
Sep 23, 2026, 06:07Hoori Shahwar: Cerebral Venous Sinus Thrombosis Diagnosis and Management
-
Sep 23, 2026, 06:06Advancing Hemophilia Care and Patient Advocacy in Bangladesh – World Federation of Hemophilia
-
Sep 23, 2026, 05:54Bringing the Global Thrombosis and Haemostasis Community Together in 2027 – ISTH
-
Sep 23, 2026, 04:34David Akande: When Sickle Cell Crises Have No Clear Trigger
-
Sep 23, 2026, 04:13Jean Connors: Safety of Heparin Re-Exposure in Patients with Remote HIT
-
Sep 23, 2026, 04:09Beth Psaila: Applications Now Open for the Gordon Research Conference on Megakaryocytes and Platelets